Imaris for Core Facilities (CF) Annual Lease

PRE-SOLICITATION NOTICE OF INTENT

NON-COMPETITIVE

SUBJECT

Imaris for Core Facilities (CF) Annual Lease

REGULATORY AUTHORITY

This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures, and the procedures prescribed in FAR Subpart 13.106-1(b)(1), Soliciting from a single source.

The resultant contract will include all applicable provisions and clauses of the FAR in effect through the Federal Acquisition Circular (FAC) 2022-08, dated 10/28/2022.

DESCRIPTION

Pursuant to FAR Subpart 5.2—Synopses of Proposed Contract Actions,

THIS IS A PRE-SOLICITATION NOTICE OF INTENT TO AWARD A CONTRACT WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION. 

The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Institute of Neurological Disorders and Stroke (NINDS) intends to negotiate and award a purchase order for Imaris for Core Facilities (CF) Annual Lease used by its researchers and scientists in the Laboratory of Circuits, Synapses, and Molecular Signaling (LCSMS).

The National Institutes of Health (NIH) is the nation’s leading medical research agency and the primary Federal agency whose mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability, conducting, supporting and making medical discoveries that improve people’s health and save lives.

The National Institute of Neurological Disorders and Stroke (NINDS) is a part of the National Institutes of Health (NIH), which mission it is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease for all people.

The main goal of the LCSMS (part of NINDS) is to investigate the neural mechanisms and circuits underlying neuropsychiatric and neurodegenerative disorders. The lab requires a customizable, high-powered software for the analysis of fluorescent widefield and confocal images. Continued renewal is essential for the lab and cost-effective vs. purchasing the license outright. Using Imaris software will give the lab an analysis software capable of preprocessing and analyzing microscopy images of all types and sizes. The lab has already purchased and renewed this license for 3 years. Following five years of continuous renewal, the lab will have the option to own the license outright.

ANTICIPATED SOURCE

Andor Technology Inc. (Previously Oxford Instruments)

300 Baker Avenue

Suite 150

Concord MA 01742

POC: Kirsti Golgotiu ; k.golgotiu@andor.com

PERIOD OF PERFORMANCE

The anticipated period of performance shall include one 12-month base period as follows.

Base Period:                            9/30/2024-9/29/2025

PLACE OF PERFORMANCE

N/A

REASON FOR NON-COMPETITIVE ACTION

The essential characteristics of the Imaris Annual Lease for the LCSMS that limit the availability to a sole source are that the Government has already purchased and renewed this license for 3 of the 5 years necessary to own it outright.  

CLOSING STATEMENT

This synopsis is not a request for competitive proposals.  All responsible sources may submit a capability statement, however, which shall be considered by the agency.  Responses to this notice must include clear and convincing evidence of the offeror’s capability of fulfilling the requirement. 

In addition, the Unique Entity Identifier (UEI), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response.  All offerors must have an active registration in the System for Award Management (SAM).

A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government.  The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.  

All responses must be received by 2:00 P.M., Eastern Standard Time on June 18, 2024.

Responses must be submitted electronically to the Contract Specialist, Cassandra Conley, at cassandra.conley@nih.gov.

Fax responses are not accepted.